Business CircleBusiness Circle
  • Home
  • AI News
  • Startups
  • Markets
  • Finances
  • Technology
  • More
    • Human Resource
    • Marketing & Sales
    • SMEs
    • Lifestyle
    • Trading & Stock Market
What's Hot

ChatGPT is $20/month. Get GPT, Claude, and Gemini for a full year for $30.

July 12, 2026

Johnson & Johnson Travel Ready First Aid Kit 80-Piece only $6.04 shipped (Reg. $14+)

July 12, 2026

B2B Reads: AI Overload, Sales Compensation, and Lead Gen Timing

July 12, 2026
Facebook Twitter Instagram
Monday, July 13
  • Advertise with us
  • Submit Articles
  • About us
  • Contact us
Business CircleBusiness Circle
  • Home
  • AI News
  • Startups
  • Markets
  • Finances
  • Technology
  • More
    • Human Resource
    • Marketing & Sales
    • SMEs
    • Lifestyle
    • Trading & Stock Market
Subscribe
Business CircleBusiness Circle
Home » Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts
Finances

Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts

Business Circle TeamBy Business Circle TeamJanuary 10, 2026No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts
Share
Facebook Twitter LinkedIn Pinterest Email


Soleno Therapeutics, Inc. (NASDAQ:SLNO) is without doubt one of the 12 Shares that Will Bounce Again Based on Wall Road Analysts. On December 11, LifeSci Capital reiterated its Purchase ranking on Soleno Therapeutics, Inc. (NASDAQ:SLNO) with a worth goal of $110 on the inventory.

On December 8, Piper Sandler recognized Soleno Therapeutics, Inc. (NASDAQ:SLNO) as one in every of a number of commercial-stage biotech corporations anticipated to expertise transformational progress in 2026. Based on a analysis notice following the agency’s three-day Healthcare Convention, discussions with administration groups offered clearer perception into upcoming launches and attainable approvals.

Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts
Soleno Therapeutics (SLNO) Amongst Shares That Will Bounce Again Based on Analysts

Piper Sandler expressed improved confidence in these corporations, together with Soleno Therapeutics, Inc. (NASDAQ:SLNO), and famous that these corporations have a stable plan to start or progress drug launches.

In different information, on January 5, Soleno Therapeutics, Inc. (NASDAQ:SLNO) introduced that outcomes from a pivotal research of VYKAT XR had been printed within the Journal of Medical Endocrinology and Metabolism (JCEM). The research was a key a part of the Part 3 medical program, which established the efficacy and security of the drug. It additionally supported the drug’s approval by the FDA as the primary and solely therapy for hyperphagia in folks residing with Prader-Willi syndrome.

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a biopharmaceutical firm targeted on growing novel therapeutics for the therapy of uncommon illnesses.

Whereas we acknowledge the potential of SLNO as an funding, we imagine sure AI shares provide better upside potential and carry much less draw back threat. When you’re searching for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.

READ NEXT: 10 Greatest US Penny Shares to Purchase and 10 Greatest New Penny Shares to Make investments In.

Disclosure: None. This text is initially printed at Insider Monkey.



Source link

among analysts bounce SLNO Soleno stocks Therapeutics
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Business Circle Team
Business Circle Team
  • Website

Related Posts

Johnson & Johnson Travel Ready First Aid Kit 80-Piece only $6.04 shipped (Reg. $14+)

July 12, 2026

AST SpaceMobile Has a Time-Sensitive Opportunity Worth Acting On Now

July 12, 2026

Top analysts are confident about these 3 stocks for the long haul

July 12, 2026

Indian Bank aims to recover Rs 5,500 from bad loans during FY27: MD Binod Kumar

July 12, 2026
LATEST UPDATES

ChatGPT is $20/month. Get GPT, Claude, and Gemini for a full year for $30.

July 12, 2026

Johnson & Johnson Travel Ready First Aid Kit 80-Piece only $6.04 shipped (Reg. $14+)

July 12, 2026

B2B Reads: AI Overload, Sales Compensation, and Lead Gen Timing

July 12, 2026

MVP Development on a Founder Budget: What to Cut and What to Keep

July 12, 2026

Title VII plaintiffs don’t need to mitigate emotional distress damages, 5th Circuit says

July 12, 2026

AST SpaceMobile Has a Time-Sensitive Opportunity Worth Acting On Now

July 12, 2026

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Business, Finance and Market Growth News Site

Important Pages
  • Advertise with us
  • Submit Articles
  • About us
  • Contact us
Recent Posts
  • ChatGPT is $20/month. Get GPT, Claude, and Gemini for a full year for $30.
  • Johnson & Johnson Travel Ready First Aid Kit 80-Piece only $6.04 shipped (Reg. $14+)
  • B2B Reads: AI Overload, Sales Compensation, and Lead Gen Timing
© 2026 BusinessCircle.co
  • Privacy Policy
  • Terms and Conditions
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA

Type above and press Enter to search. Press Esc to cancel.